Physician profile
Kyle Graham Cologne
NPI 1164678082
$9,905.22
in general payments reported to CMS, 2019-2025
17 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $7,632 · 2023: $556 · 2024: $669 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $7,358.59 | 2019-2020 | |
| Boston Scientific Corporation | $738.83 | 2019-2025 | General - Hemostasis, Bodyguardian |
| Intuitive Surgical, INC. | $296.87 | 2019 | |
| Guard Medical INC. | $221.03 | 2024 | Npseal Large |
| Medtronic, INC. | $198.06 | 2023-2024 | Interstim, Rapidvac |
| Aroa Biosurgery Incorporated | $197.49 | 2023-2025 | |
| Conmed Corporation | $175.00 | 2023 | Airseal |
| Thd America, INC. | $170.45 | 2020 | |
| Innovation Technologies INC | $135.48 | 2024 | Irrisept |
| Acelrx Pharmaceuticals, INC. | $123.34 | 2019 | |
| Integra Lifesciences Corporation | $105.43 | 2023 | Integra, Surgimend, Omnigraft |
| Davol INC. | $60.79 | 2024 | Phasix Mesh |
| Baxter Healthcare | $45.35 | 2023 | |
| Biotissue Holdings INC. | $31.57 | 2025 | |
| Heron Therapeutics, INC. | $28.32 | 2024 | Zynrelef, Aponvie |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.62 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Cologne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.